E2F8 and hepatocellular carcinoma: In particular, recent literature has shown that the expression of E2F8 is noticeably enhanced in multiple carcinomas, including lung cancer, breast cancer, and hepatocellular carcinoma [12,13,14], implying that E2F8 is involved in oncogenesis and cancer progression.